MicroRNA mimetic for use in cancer treatment
Specific microRNA mimetics like miR-323a, miR-3127, and miR-3161, alone or in combination, provide effective inhibition of tumor cell survival and proliferation, addressing the limitations of existing mimetics in cancer treatment.
FR3169480A1Pending Publication Date: 2026-06-12UNIV CLAUDE BERNARD LYON 1 +3
Patent Information
- Authority / Receiving Office
- FR · FR
- Patent Type
- Applications
- Current Assignee / Owner
- UNIV CLAUDE BERNARD LYON 1
- Filing Date
- 2024-12-09
- Publication Date
- 2026-06-12
Smart Images

Figure 00000023_0000 
Figure 00000023_0001 
Figure 00000024_0000
Abstract
The invention relates to a microRNA mimetic or a combination of microRNA mimetics, for use in the prevention and / or treatment of cancer in a patient, said microRNA mimetic being selected from a miR323a, miR3127 and / or miR3161 mimetic, alone or in combination.
Need to check novelty before this filing date? Find Prior Art